Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: Final analysis of a phase 2 study - Kastritis, E.; Gavriatopoulou, M.; Kyrtsonis, M.-C.; Roussou, M.; Hadjiharissi, E.; Symeonidis, A.; Repoussis, P.; Michalis, E.; Delimpasi, S.; Tsatalas, K.; Tsirigotis, P.; Vassou, A.; et al. (Blood, 2015)